What benefits can biosimilars bring to the NHS?

Alastair Henderson

Alison Moore reports on an HSJ roundtable which explored how the biosimilars market can be expanded, what the potential benefits and challenges are, and what needs to be done to increase uptake

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Enquire about multi-user access